250+ studies mainly in gut health and natural defenses in adults and children
Used since 1990, Lactobacillus rhamnosus GG is one of the most renown probiotic bacteria in the world, selected for its prolific and probiotic qualities demonstrated in in vitro and in vivo studies:
- Survival at gastric acid pH and in medium containing bile
- Adhesion to enterocytes
- Inhibition of intestinal pathogens
- Intestinal mucosa protection
- Immunomodulation
For other use than food/dietary supplements
L. rhamnosus GG has been studied in over 250 clinical trials, demonstrating its effectiveness in the gut health area, including gastrointestinal infections and diarrhea, antibiotic and Clostridium difficile associated diarrhea, irritable bowel syndrome, inflammatory bowel disease, and showing its benefits in the natural defenses segment for respiratory tract infections, allergies, or atopic dermatitis.
From a human origin, and analyzed in a wide range of populations, from babies and children to pregnant women and adults, L. rhamnosus GG is safe and strongly recommended by pediatricians (European Paediatric Association and the Union of the National European Paediatric Societies and Associations – EPA/UNEPSA) for its beneficial effects on common infections, antibiotic-associated diarrhea and acute gastroenteritis as an adjunct to the oral rehydration therapy [Hojsak, 2018].
Health claims approved in Canada on acute diarrhea and Antibiotic-Associated Diarrhea
- Helps to manage acute infectious diarrhea
- Helps to manage and/or reduce the risk of antibiotic-associated diarrhea